- Home
- HGV vs VKTX Comparison
HGV vs VKTX Comparison
Compare HGV & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HGV | VKTX |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HGV | VKTX |
|---|---|---|
| Price | $50.50 | $28.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $52.13 | ★ $95.86 |
| AVG Volume (30 Days) | 1.1M | ★ 1.9M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.78 | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $5,047,000,000.00 | N/A |
| Revenue This Year | $25.30 | N/A |
| Revenue Next Year | $1.98 | N/A |
| P/E Ratio | $64.76 | ★ N/A |
| Revenue Growth | ★ 1.33 | N/A |
| 52 Week Low | $36.79 | $22.96 |
| 52 Week High | $53.82 | $43.15 |
Technical Indicators
Market Signals| Indicator | HGV | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 43.67 |
| Support Level | $43.95 | $25.77 |
| Resistance Level | $53.82 | $32.92 |
| Average True Range (ATR) | 1.84 | 1.29 |
| MACD | -0.13 | -0.11 |
| Stochastic Oscillator | 50.47 | 30.67 |
Price Performance
Historical ComparisonAbout HGV Hilton Grand Vacations Inc.
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts and timeshare plans under the Hilton Grand Vacations brand. The company operates in two segments: Real estate sales and financing, and Resort operations and club management. The Real estate sales and financing segment generates revenue from VOI sales and consumer financing, including interest income from loans to members. The Resort operations and club management segment generates revenue from resort management services, club membership fees, and rental of available inventory. The majority of the company's revenue is earned through the Real estate sales and financing segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.